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Abstract
Background: Poorer self-rated health (SRH) predicts worse health outcomes, even when
adjusted for objective measures of disease at time of rating. Twin studies indicate SRH
has a heritability of up to 60% and that its genetic architecture may overlap with that of
personality and cognition.
Methods: We carried out a genome-wide association study (GWAS) of SRH on 111 749
members of the UK Biobank sample. Univariate genome-wide complex trait analysis
(GCTA)-GREML analyses were used to estimate the proportion of variance explained by
all common autosomal single nucleotide polymorphisms (SNPs) for SRH. Linkage dis-
equilibrium (LD) score regression and polygenic risk scoring, two complementary meth-
ods, were used to investigate pleiotropy between SRH in the UK Biobank and up to 21
health-related and personality and cognitive traits from published GWAS consortia.
Results: The GWAS identified 13 independent signals associated with SRH, including
several in regions previously associated with diseases or disease-related traits. The
strongest signal was on chromosome 2 (rs2360675, P ¼ 1.77 x 10-10) close to KLF7. A se-
cond strong peak was identified on chromosome 6 in the major histocompatibility region
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(rs76380179, P ¼ 6.15 x 10-10). The proportion of variance in SRH that was explained by
all common genetic variants was 13%. Polygenic scores for the following traits and dis-
orders were associated with SRH: cognitive ability, education, neuroticism, body mass
index (BMI), longevity, attention-deficit hyperactivity disorder (ADHD), major depressive
disorder, schizophrenia, lung function, blood pressure, coronary artery disease, large
vessel disease stroke and type 2 diabetes.
Conclusions: Individual differences in how people respond to a single item on SRH are
partly explained by their genetic propensity to many common psychiatric and physical
disorders and psychological traits.
Key words: Self-rated health, genome-wide association study, pleiotropy, heritability, genetic correlation, polygenic score
Introduction
There is considerable evidence that how individuals re-
spond to one simple question asking them to evaluate their
current state of health is a powerful predictor of future
health outcomes. Poorer self-rated health (SRH) has been
associated with increased mortality from all causes1–4 and
from several specific causes including cardiovascular dis-
ease,5–7 diabetes,8 respiratory disease,8 cancer8 and infec-
tious disease.8 Poorer SRH has also been linked in
prospective studies to an increased risk of the onset of cer-
tain diseases, in particular, heart disease,9–11 cancer11 and
type 2 diabetes,12 with a higher likelihood of incident ad-
mission to psychiatric hospital,11 and with increased inci-
dence of cognitive or functional impairment.13 People with
a greater burden of chronic disease are more likely to rate
their health as poor or fair14 but, in general, adjustments
for objective measures of disease, common risk factors and
health behaviours, at the time that individuals rated their
health, explain only a small part of the association between
SRH and later morbidity or mortality.
Evidence for the heritability of SRH comes from several
twin studies,15–17 which provide estimates of the percent-
age variance explained by genetic factors which range
from  20% to  60%.18,19 Studies using molecular gen-
etic methods also provide evidence for heritability: for
instance, the genome-wide complex trait analysis (GCTA-
GREML) method20 was used to estimate that common sin-
gle nucleotide polymorphisms (SNPs) account for 18% of
the variation in SRH (N ¼ 4233).21 A multivariate twin
study22 indic.ated appreciable genetic overlap between
SRH and the phenotypically-correlated traits of optimism
and self-rated mental health. However, there were also
substantial genetic influences unique to SRH (see also23).
In addition, Svedberg et al.24 showed that SRH and (meas-
ured) cognitive ability have a shared genetic basis using
twin models; for older adults, genetic factors were entirely
responsible for the phenotypic relation between SRH and
cognitive ability. To date, studies have been insufficiently
powered to detect variants from individual genes that re-
late to SRH.
Previous research suggests that perceptions of health are
driven in part by psychological factors. There is evidence
that people who are higher in the personality trait neuroti-
cism—the tendency to experience negative emotions—are
more likely to rate their health as being poor,25–27 and
have a steeper decline in health ratings over time.28
Another psychological factor that has been linked with
poorer SRH in cross-sectional surveys is lower cognitive
ability. Whereas there is some indication that poorer per-
ception of health can be a risk factor for subsequent cogni-
tive decline, longitudinal evidence suggests that having
lower cognitive ability in youth increases the risk of poorer
SRH decades later.29 Part of this link may be due to lower
educational attainment—itself consistently linked with
poorer SRH.30–32 It has been suggested that psychosocial
resources may enable the highly educated to cope better
with the negative effects of worsening health, and that this
may in part explain why such individuals have better
SRH.32,34
Key messages
• Genetic variants associated with common diseases and psychological traits are associated with self-rated health.
• The SNP-based heritability of self-rated health is 0.13 (SE 0.006).
• There is pleiotropy between self-rated health and psychiatric and physical diseases and psychological traits.
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The aim of the present study was to add substantially to
the understanding of the genetic mechanisms and genetic
architecture of SRH. Using the large UK Biobank geno-
typed sample, we conducted a genome-wide analysis of
SRH, we estimated its SNP-based heritability and we
studied its pleiotropy with physical and mental health and
with personality and cognitive traits.
Methods
Cohorts and measures
The UK Biobank is a health resource facilitating the study
of the origins of a wide range of illnesses.35 Around 500
000 individuals aged between 37 and 73 years were re-
cruited in the UK between 2006 and 2010. They under-
went testing of cognitive abilities and physical and mental
health examinations, completed questionnaires about life-
style, socio-demographic background and family medical
history and agreed to have their health followed longitu-
dinally. For the present study, genome-wide genotyping
data were available for 112 151 individuals (58 914 fe-
males, 53 237 males) aged 40 to 73 years (mean ¼ 56.91
years, SD¼ 7.93). Figure 1 shows the participant selection
for this study.
Ethics
UK Biobank received ethical approval from the Research
Ethics Committee (REC reference 11/NW/0382).
This study has been completed under UK Biobank
application 10279.
Self-rated health
Participants were asked the question, ‘In general how
would you rate your overall health?’ Possible answers were
‘Excellent/Good/Fair/Poor/Do not know/Prefer not to an-
swer’. We created a four-category SRH variable indexing
how each participant rated their health ranging from ‘ex-
cellent’ to ‘poor’; excluding those that responded with ‘do
not know’ or ‘prefer not to answer’. For the phenotypic
correlations, LD score regression and polygenic profile
score analyses used in this study, a higher score for SRH in-
dicates a better health rating.
Neuroticism
Participants completed 12 questions of the Eysenck
Personality Questionnaire-Revised Short Form (EPQ-R
Short Form)36,37 neuroticism scale. Neuroticism refers to
the relatively stable personality trait that assesses indi-
vidual differences in the tendency to experience negative
emotions. A summary score was derived to obtain a meas-
ure of neuroticism. The EPQ-R Short Form has been
shown to correlate highly with other well-validated
Neuroticism scales, 38 and has shown a high genetic correl-
ation (0.91) with psychological distress examined in a non-
psychiatric population using the 30-item General Health
Questionnaire.39
Education
Education was measured by the question, ‘Which of the
following qualifications do you have? (You can select more
than one)’. Possible answers were: ‘College or University
Degree/A levels or AS levels or equivalent/O levels or
GCSE or equivalent/CSEs or equivalent/NVQ or HND or
HNC or equivalent/Other professional qualifications e.g.
nursing, teaching/None of the above/Prefer not to answer’.
For the present study, a binary education variable was cre-
ated to indicate whether or not a participant had a college
or university-level degree; excluding those who responded
with ‘prefer not to answer’. Previous studies have used
similar binary variables as a ‘proxy-phenotype’ for cogni-
tive ability.40
Intelligence
Intelligence was measured by a 13-item test with a time
limit of 2 min, completed by 36 035 individuals. Six items
were verbal and seven numerical. An example of a verbal
question is ‘Bud is to flower as child is to?’ Possible an-
swers were: ‘Grow/Develop/Improve/Adult/Old/Do not
know/Prefer not to answer’). An example of a numerical
All recruited participants 
(N = 502 655) 
Interim genetic data 
release 
(N = 152 729)
Quality control (QC) 
(N = 112 151)
Answered SRH question 
+ QC 
(N = 111 749) 
Exclusions based on: 
- non-British ancestry  
- high missingness 
- relatedness 
- QC failure in UK Bileve 
- gender mismatch 
Figure 1. Flow diagram of participant selection.
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question is ‘If 60 is more than half of 75, multiply 23 by
three. If not, subtract 15 from 85. Is the answer?’ Possible
answers were: ‘68/69/70/71/72/Do not know/Prefer not to
answer’. The Intelligence score was the total score out of
13 items. The Cronbach a coefficient for the 13 items
was 0.62.
Phenotypic correlations
Phenotypic correlation coefficients were calculated be-
tween SRH, and neuroticism, education, intelligence and
mortality in the UK Biobank. Cox proportional hazard
ratios were calculated for all-cause mortality according to
the SRH categories (Poor to Excellent).
Genotyping and quality control
A total of 152 729 UK Biobank samples were genotyped
using either the UK BiLEVE (N ¼ 49 979) or the UK
Biobank axiom array (N ¼ 102 750). UK BiLEVE samples
were selected based on lung function and smoking behav-
iour from participants with self-declared European ances-
try.41 The UK Biobank axiom array samples were selected
using an algorithm developed to prevent clustering of
phenotypes and assessment centres. Array design, genotyp-
ing details and, quality control details can be found else-
where.41 Genotyping was performed on 33 batches of 
4700 samples by Affymetrix. Initial quality control (QC)
of the genotyping data was also performed by Affymetrix.
Further details are available of the sample processing spe-
cific to the UK Biobank project [http://biobank.ctsu.ox.ac.
uk/crystal/refer.cgi?id ¼ 155583] and the Axiom array
[http://media.affymetrix.com/support/downloads/manuals/
axiom_2_assay_auto_workflow_user_guide.pdf]. Before
the release of the UK Biobank genetic data a stringent QC
protocol was applied, which was performed at the
Wellcome Trust Centre for Human Genetics (WTCHG).
Details of this process can be found at [http://biobank.ctsu.
ox.ac.uk/crystal/refer.cgi?id ¼ 155580]. Before the ana-
lyses described below, further quality control measures
were applied. Individuals were removed sequentially based
on non-British ancestry (within those who self-identified as
being British, principal component analysis was used to re-
move outliers), high missingness, relatedness, QC failure in
UK Bileve and gender mismatch. A sample of 112 151 indi-
viduals remained for further analyses.
Imputation
An imputed dataset was made available in which the UK
Biobank interim release was imputed to a reference set
combining the UK10K haplotype and 1000 Genomes
Phase 3 reference panels. Further details can be found at
the following URL: [http://biobank.ctsu.ox.ac.uk/crystal/
refer.cgi?id ¼ 157020]. The association analyses were re-
stricted to autosomal variants with a minor allele fre-
quency greater than 0.1% and an imputation quality score
of 0.1 or greater (N  17.3m SNPs). An imputation quality
score of 0.1 was chosen, rather than the more commonly
used 0.3–0.5, due to the relatively large sample size of UK
Biobank. An imputation score of 0.1 on 150 000 individ-
uals corresponds to an effective sample size of 15 000
individuals.
Curation of summary results from GWAS
consortia on health-related variables
In order to conduct LD score regression and polygenic pro-
file score analyses between the UK Biobank SRH and the
genetic predisposition to psychiatric, physical and cogni-
tive variables, we gathered 21 sets of summary results from
international GWAS consortia of physical and psychiatric
diseases and health-related traits and three sets of summary
results from GWAS of the following UK Biobank variables:
neuroticism, education and intelligence. Details of the
health-related variables, the consortia’s websites, key refer-
ences and number of subjects included in each con-
sortium’s GWAS are given in Supplementary materials and
Supplementary Table 1 (available as Supplementary data
at IJE online).
Association analyses
The UK Biobank measure of SRH was adjusted for age,
gender, assessment centre, genotyping batch, genotyping
array and 10 principal components for population stratifi-
cation before the association analyses. The distribution of
SRH was visually inspected and no exclusions were made;
111 749 individuals with both SRH and genotype informa-
tion remained for further analyses.
SNPTEST v2.5.142 was used to perform genotype-
phenotype association analyses on the imputed dataset.
SNPTEST v2.5.1 can be found at the following URL:
[https://mathgen.stats.ox.ac.uk/genetics_software/snptest/
snptest.html#introduction]. The ‘frequentist 1’ option was
used to specify an additive model. Genotype dosage scores
were used to account for genotype uncertainty.
The number of independent signals for the genotype-
phenotype analyses was determined using LD clumping,
using the 1000 Genomes as a measure of LD between
SNPs. First, SNPs with a genome-wide significant associ-
ation with SRH (P < 5  10-8) were selected as index
SNPs. Second, SNPs within 500 kb and in LD of r2 > 0.1
with the index SNP were included in the clump. SNPs from
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within this region were assigned to the clump if they had a
P-value < 1  10-5. In addition, conditional analyses were
performed using SNPTEST v2.5.142 for each genome-wide
significant region with evidence of multiple signals, to
identify potential secondary signals.
Human leucocyte antigen (HLA) classical allele imput-
ation was performed using HLA genotype imputation with
attribute bagging (HIBAG).43 HLA classical alleles were
imputed in six genes (HLA-A, HLA-B, HLA-C, HLA-
DQA1, HLA-DQB1and HLA-DRB1). Individuals with
imputation score < 0.8 and alleles with frequency < 0.01
were removed before analysis. Linear regression correcting
for age, gender, assessment centre, genotyping batch, geno-
typing array, imputation quality score and 10 principal
components was performed to identify associations be-
tween HLA alleles and SRH.
MAGMA44 was used to perform gene-based association
analyses. The results of the GWAS were used to derive the
gene-based statistics. Genetic variants were assigned to
genes based on their position according to the NCBI 37.3
build with no additional boundary placed around the
genes; this resulted in a total of 18 116 genes being ana-
lysed. The European panel of the 1000 Genomes data
(phase 1, release 3) was used as a reference panel to ac-
count for linkage disequilibrium. A genome-wide signifi-
cance threshold for gene-based associations was
calculated using the Bonferroni method (a¼ 0.05/18 116;
P < 2.76  106).
Functional annotation and gene expression
For the 13 independent genome-wide significant SNPs
identified by LD clumping, evidence of expression quanti-
tative trait loci (eQTL) and functional annotation were
explored using publicly available online resources. The
Genotype-Tissue Expression Portal (GTEx) [http://www.
gtexportal.org] was used to identify eQTLs associated with
the SNPs. Functional annotation was investigated using
the Regulome DB database45 [http://www.regulomedb.
org/]. Regulome DB was used to identify regulatory DNA
elements in non-coding and intergenic regions of the gen-
ome in normal cell lines and tissues.
Estimation of SNP-based heritability
Univariate GCTA-GREML20 analyses were used to esti-
mate the proportion of variance explained by all genotyped
autosomal SNPs for SRH with a minor allele frequency >
0.01. A relatedness cut-off of 0.025 was used in the gener-
ation of the genetic relationship matrix.
Genetic analyses: DEPICT
DEPICT46 was used to conduct three analyses; gene priori-
tization, gene-set analysis and tissue enrichment. The full
GWAS output of SRH was clumped using PLINK to derive
independent regions of the genome showing evidence of as-
sociation. Next, DEPICT was used to determine if these in-
dependent regions overlapped with genes that share
biological function, by comparing the empirically-derived
clumps with randomly-selected loci drawn from across the
genome and matched for gene density. DEPICT tests the
hypothesis that genes showing a true association with SRH
will be involved in the same mechanisms that in turn con-
tribute toward this phenotype. Clumping was performed
using index SNPs of P< 1 x 10-5 with a 500-kb boundary
including SNPs in LD of r2 > 0.1.
Stratified LD score regression
Stratified LD score regression was used in order to deter-
mine which regions of the genome are contributing to-
wards variation in self-rated health. We follow the same
data processing pipeline as Finucane et al.47 We first parti-
tioned the full genome-wide data set into 24 functional an-
notations. An additional 500-bp boundary was placed
around each of the regions captured by the annotations in
order to avoid estimates being biased upwards by captur-
ing enrichment from nearby SNPs, and a 100-bp window
was placed around chromatin immunoprecipitation and
sequencing (ChIP-seq) peaks. This resulted in a baseline
model consisting of a total of 52 overlapping functional
annotations. The 24 main annotations included gene-sets
from the digital genomic footprint (DGF ENCODE), tran-
scription factor binding sites (TFBS)48,49 and DNase I
hypersensitivity sites (DHS),50 the fetal gene-set being only
those that were found within the fetal cell whereas the
DHS grouping corresponded to all sites. Coding regions,
3’UTR, 5’UTR, promoter and intron49,51 gene-sets were
used. Regions of the genome that have been evolutionarily
conserved along the mammalian line52,53 were also
included as were CTCF, promoter-flanking, transcribed,
transcription start sites (TSS) and strong enhancer and
weak enhancer categories.54 Finally, cell type-specific
H3K4me1, H3K4me3 and H3K9ac data were taken from
work performed on the Epigenomics Roadmap.55 An add-
itional version of H3k27ac was also included,56 as were
clusters of enhancers that show a high level of activity
(Super enhancers).56 This resulted in the 52 groupings that
formed the baseline model.
In order to examine the role of specific tissue types, we
then grouped the four histone marks (H3K4me1,
H3K4me3, H3K9ac and H3K27ac) into 10 broad tissue
International Journal of Epidemiology, 2016, Vol. 0, No. 0 5
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types. These 10 groups correspond to histone marks found
in the central nervous system (CNS, and immune, haema-
topoietic, adrenal/pancreas, cardiovascular, connective tis-
sue, gastrointestinal, kidney, liver, skeletal muscle and
other systems.
The heritability Z-score for the SRH data set was 15.36,
indicating that there was a sufficiently large polygenic sig-
nal for use with stratified LD score regression. The herit-
ability of regions of the genome can be derived using
stratified LD score regression.47 This heritability estimate
can then be used to derive an enrichment metric, defined as
the proportion of heritability the region captures over the
proportion of SNPs that lie within the functional annota-
tion, Pr(h2)/Pr(SNPs). Although using LD score regression
of GWAS summary statistics that have undergone correc-
tion for population stratification can result in an attenu-
ation of the heritability estimate derived, this will not bias
the enrichment metric as regions of the genome will be
influenced equally. LD scores were calculated from the
European samples in the 1000 Genomes project and only
included the HapMap 3 SNPs with a minor allele frequency
(MAF) of> 0.05. False discovery rate (FDR)57 was applied
to the full baseline model (52 tests) in order to control for
the number of tests performed. For the tissue-specific ana-
lysis, 10 tests were controlled for using FDR correction.
Gene-set enrichment analysis
Gene-set enrichment analysis was performed using
MAGMA.44 The full set of MsigDB canonical pathways58
was used to examine if any of the gene-sets contained
showed an association with self-rated health. Competitive
testing was used to determine statistical significance, as
this provides a means of correcting for the baseline level of
association44 found in the self-rated health data set. The
competitive test used in MAGMA is equivalent to compar-
ing the mean association of the genes within each gene-set
to the mean association of all the genes not contained
within the gene-set. FDR correction was used to control
for the number of tests performed.
Two methods have been used to compute genetic associ-
ations between health-related variables from GWAS con-
sortia and SRH in UK Biobank: LD score regression and
polygenic profile score analyses, both providing a different
metric to examine pleiotropy between two traits. LD score
regression was used to determine the degree of overlap in
polygenic architecture between two traits, by deriving gen-
etic correlations. The polygenic profile score method was
used to predict the phenotypic variance in SRH using sum-
mary data from GWASs of health-related variables to cre-
ate polygenic profile scores in the UK Biobank sample.
Both LD score regression and polygenic profile score ana-
lyses depend on traits being highly polygenic in nature, i.e.
a large number of variants of small effect contributing to-
ward phenotypic variation.59,60 LD score regression was
performed between the 16 health-related traits from
GWAS consortia and three UK Biobank traits, whereas the
polygenic profile score analyses were performed on the
complete set of 21 health-related traits from GWAS con-
sortia, as this method requires independent samples.
LD score regression
LD score regression uses the information that for a given
SNP, the effect size is a function of this particular SNP’s
LD with other SNPs.59,61 Assuming a trait with a polygenic
architecture, SNPs with high LD will have stronger effects
on average than SNPs with low LD. LD score regression
estimates the genetic effect on a trait by measuring the ex-
tent to which the observed effect sizes from a GWAS can
be explained by LD. The covariance between the genetic
effects in two traits can be indexed in a similar way; nor-
malizing this genetic covariance by the heritability of the
trait will estimate the genetic correlation between the two
traits.
In the present study, LD score regression has been used
to derive genetic correlations between summary statistics
from 16 health-related GWAS consortia and three UK
Biobank GWA studies (Intelligence, Education and
Neuroticism), and the UK Biobank SRH measure. We fol-
lowed the data processing pipeline devised by Bulik-
Sullivan et al.59 In order to ensure that the genetic correl-
ation for the Alzheimer’s disease phenotype was not driven
by a single locus nor biased the fit of the regression model,
a 500-kb region centred on the APOE locus was removed
and this phenotype was re-run. This additional model is
referred to in the Tables and Figures as ‘Alzheimer’s dis-
ease (500 kb)’.
Polygenic profile score analyses
The UK Biobank genotyping data required recoding from
numeric (1, 2) allele coding to standard ACGT format be-
fore being used in polygenic profile scoring analyses. This
was achieved using a bespoke programme developed by
one of the present authors (D.C.M.L.), details of which are
provided in the Supplementary materials, available as
Supplementary data at IJE online.
PRSice62 was used to create polygenic profile scores
from 21 health-related phenotypes of published GWAS in
all genotyped participants (Supplementary Table 1, avail-
able as Supplementary data at IJE online). SNPs with
a minor allele frequency < 0.01, as well as strand-
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ambiguous SNPs, were removed before creating the scores.
Clumping was used to obtain SNPs in linkage equilibrium
with an r2 < 0.25 within a 200-bp window. The scores
were calculated as the sum of alleles associated with the
phenotype of interest across many genetic loci, weighted
by their effect sizes estimated from the GWAS summary
statistics. The conventional approach was used to create
polygenic profile scores that included variants according to
the significance of their association with the phenotype, ex-
ceeding five predefined P-value thresholds of 0.01, 0.05, 0.
1, 0.5 and all SNPs. Throughout the paper, the most pre-
dictive threshold will be presented in the main tables; the
full results, including all five thresholds, can be found in
Supplementary Table 10, available as Supplementary data
at IJE online.
Regression models were used to examine the associ-
ations between the 21 polygenic profiles and SRH, adjust-
ing for age at measurement, sex, genotyping batch and
array, assessment centre and the first 10 genetic principal
components to adjust for population stratification. All
polygenic profile score association analyses were per-
formed in R,63 and the obtained P-values from each test
were corrected for multiple testing using the false discovery
rate (FDR) method.57 Sensitivity analyses were performed
in order to test whether the results are driven by individ-
uals with a given illness. This was done by removing indi-
viduals with a self-reported clinical diagnosis of coronary
artery disease (N ¼ 5300), type 2 diabetes (N ¼ 5800) and
hypertension (N ¼ 26 912) from the relevant analyses.
More details can be found in the Supplementary materials.
Multivariate regression has been performed including all
FDR significant polygenic profile scores and the covariates
described earlier.
Mendelian randomization
To begin to address causality, a Mendelian randomization
approach was used to investigate if genetically determined
BMI was associated with SRH in UK Biobank. A polygenic
risk score (PGRS) for BMI was created, using PRSice,62 for
each UK Biobank subject using the SNPs associated with
BMI at a genome-wide association significance level in the
GIANT consortium;64 90 of the 97 SNPs were available
and not strand-ambiguous in the UK Biobank data set
(Supplementary Table 2). Linear regressions correcting for
age, gender, assessment centre, genotyping batch, genotyp-
ing array and 10 principal components were used to exam-
ine the associations between BMI and BMI PGRS, and
between SRH and BMI PGRS. The PGRS was then used as
an instrumental variable in a two-stage least squares re-
gression (performed in R using the sem package) correcting
for age, gender, assessment centre, genotyping batch,
genotyping array and 10 principal components to test the
potential causal role of BMI in SRH.
Results
Phenotypic correlations
Within UK Biobank, 111 749 individuals with genotype
data completed the question ‘How would you rate your
overall health?’ Their mean (SD) score for SRH was 2.14
(0.73). SRH showed a negative correlation with the meas-
ure of neuroticism (r ¼ -0.25, P < 0.0001), indicating that
individuals who rate their health as worse had higher levels
of neuroticism. Correlations were also found for the UK
Biobank measures of intelligence and education (r¼0.146
and 0.110, P < 0.0001), indicating that individuals with
higher levels of intelligence or education are more likely to
rate their health as better. Cox proportional hazard models
for all-cause mortality adjusted for age and sex, indicated
that, compared with people with excellent SRH, the risk of
dying in those with good, fair or poor SRH is 1.37 (1.17,
1.62), 2.51 (2.12, 2.97) and 6.95 (5.79, 8.36), respectively.
Genome-wide association study
A total of 109 SNPs from 12 genomic regions were associ-
ated with SRH (Figure 2, Figure 3, Table 1; and
Supplementary Table 3, available as Supplementary data
at IJE online). A total of 11 independent signals were iden-
tified, in 10 of the genomic regions, by clumping. Two loci
contained no 1000 Genomes SNPs associated with SRH.
The chromosome 3 locus consisted of two non-1000
Genomes SNPs, and the one with the lowest P-value was
selected as an independent SNP. The chromosome 16 locus
contained a single non-1000 Genomes SNP, giving a total
of 13 independent signals. Conditional analyses did not
identify any secondary signals (Supplementary Figure 1,
available as Supplementary data at IJE online). The stron-
gest signal was on chromosome 2 and included the gene
encoding Kruppel-Like Factor 7 (KLF7). Variants in this
gene have previously been associated with obesity65 and
type 2 diabetes.66 A second strong peak was identified on
chromosome 6. Clumping identified two SNPs within the
major histocompatibility complex region (MHC).
Conditional analyses indicate that they are not independ-
ent. The MHC consists of a large number of genes that en-
code a group of cell surface molecules, which have
important roles in the immune system. HLA allele analysis
indicated that the allele with the strongest association with
SRH is HLA-DQB1*03.02 (standardized beta ¼ 0.029)
(Supplementary Tables 4–9, available as Supplementary
data at IJE online). Two independent signals were
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identified on chromosome 3, one of which was within
Bassoon Presynaptic Cytomatrix Protein (BSN), a gene
that encodes a scaffold protein expressed in the brain, is
involved with neurotransmitter release and was previously
associated with Crohn’s disease.67 A single SNP in Sterile
Alpha Motif Domain Containing 12 (SAMD12) on
chromosome 8 was associated with SRH. This region has
previously been linked to diastolic blood pressure.68 A sin-
gle SNP in Transcription Factor 4 (TCF4, chromosome
18), believed to be important in nervous system develop-
ment and previously associated with neurodevelopmental
disorders and psychiatric diseases, was also associated
with SRH.69 Single SNPs were also identified in SEC24
Family Member C (SEC24C) involved in vesicle traffick-
ing, and Shisa Family Member 9 (SHISA9), a regulator of
short-term plasticity in the dentate gyrus, on chromosomes
10 and 16, respectively.70,71
Gene-based analyses (MAGMA)
The gene-based analysis identified 36 genes across 11 gen-
omic regions associated with SRH (Supplementary Table
10, available as Supplementary data at IJE online). The
most significantly associated gene was BSN; 18 other genes
in this gene-dense region of chromosome 3 are also included
in the list. This same region previously showed suggestive
significance with general cognitive function.72 Four major
histocompatibility complex genes (HLA-DQA1, HLA-
DQB1, HLA-DRB1 and HLA-DRB5) were also associated
with SRH. Other genes of potential interest include: neu-
rexin 1 (NRXN1, chromosome 2), a synaptic adhesion
molecule previously associated with neurodevelopmental
disorders;73 autism susceptibility candidate 2 (AUTS2,
chromosome 7), previously associated with neurodevelop-
mental disorders and cancer;74 Zinc Finger Protein 652
(ZNF652, chromosome 17) a zinc finger protein previously
associated with blood pressure;75 and Additional Sex
Combs Like Transcriptional Regulator 3 (ASXL3, chromo-
some 18), previously associated with cancer.76
GCTA-GREML analysis of SNP-based heritability
The proportion of variance in SRH that was explained by
all common genetic variants was 13% (GCTA-GREML es-
timate 0.13, SE 0.006).
Functional annotation and gene expression
Using the GTEx database [http://www.broadinstitute.org/
gtex/], three cis-eQTL associations were identified for
the 13 independent genome-wide significant SNPs
(Supplementary Table 11, available as Supplementary data
at IJE online). rs907662 on chromosome 1 potentially
regulates Mannosidase, Alpha, Class 1A, Member 2
(MAN1A2), previously identified as being differentially
expressed in type 2 diabetes patients compared with normal
controls.77 rs76380179 and rs7761182 on chromosome 6
potentially regulate a number of major histocompatibility
genes. There was evidence of regulatory elements associated
with all nine of the independent genome-wide significant
SNPs included in the Regulome DB database [http://www.
regulomedb.org/] (Supplementary Table 11).
Figure 2. (A) Manhattan and (B) Q-Q plot of P-values of the SNP-based association analysis. The top line on the Manhattan plot indicates the threshold
for genome-wide significance (P < 5 x 10-8); the bottom line indicates the threshold for suggestive significance (P < 1 x 10-5).
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Gene prioritization, gene-set analysis and
tissue enrichment
The gene prioritization analysis, gene-set analysis and
the tissue enrichment, performed in DEPICT, provided
no evidence of association for any of the gene-sets or tis-
sue types considered. Full results for these analyses
can be found in Supplementary Tables 12, 13 and 14,
available as Supplementary data at IJE online.
Stratified LD score regression
The baseline model yielded eight significantly enriched func-
tional annotations (Supplementary Figure 2, available as
Supplementary data at IJE online). This indicates that the
SNPs within these annotation categories explain a greater
proportion of the variance for SRH than would be expected
based on the proportion of the total number of SNPs used
for this analysis. SNPs in evolutionarily conserved regions
Figure 3. Regional association plots of genomic regions that demonstrated genome-wide significance (P < 5 x 10-8) in the SNP-based association
analyses for self-rated health. The circles represent individual SNPs, with the shade indicating pairwise linkage disequilibrium (LD) to the SNP
indicated by the diamond (calculated from 1000 Genomes Nov 2014 EUR). The diamond indicates the most significant SNP for which LD information
was available in the 1000G reference sample. The solid line indicates the recombination rate, and –log10 P-values are shown on the y-axis.
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showed enrichment, as they account for only 2.6% of the
total number of SNPs but explain 39% of the heritability
(enrichment metric ¼ 15, SE¼2.7, P ¼ 1.27 x 10-7).
Enrichment was also found in super enhancers, which con-
tained 16.8% of the SNPs collectively explaining 27.9% of
the heritability (enrichment metric ¼ 1.66, SE¼ 0.16, P ¼
5.42 x 10-5). SNPs within 500 bp of DNase hypersensitivity
sites (DHS) also showed significant enrichment, accounting
for 50% of the total SNPs and explaining a total of 84.2%
of the heritability (enrichment metric ¼ 1.69, SE 0.197, P ¼
0.00049). A number of histone markers were also enriched,
including the H3K27ac mark, (enrichment metric ¼ 1.37,
SE 0.129, P ¼ 0.0041), the H3K4me1 mark (enrichment
metric ¼ 1.71, SE 0.25, P ¼ 0.00428) and SNPs within
500 bp of the H3K9ac mark (enrichment metric ¼ 1.84, SE
0.308, P ¼ 0.0063). The results of the cell type-specific his-
tone marks are shown in Supplementary Figure 3, available
as Supplementary data at IJE online. Histone marks that are
present in the central nervous system were significantly en-
riched. These SNPs contain 14.8% of the total number of
SNPs which collectively explained 42.8% of the heritability
(enrichment metric ¼ 2.88, SE¼0.360, P ¼ 1.68x10-7).
Gene-set enrichment analysis
None of the gene-sets examined showed statistical signifi-
cance once correction for multiple comparisons had been
applied. Supplementary Table 15 shows the full output
of the gene-set enrichment analysis (available as
Supplementary data at IJE online).
To test for pleiotropy between SRH and health-related,
personality and cognitive traits, we present LD score re-
gression and polygenic profile analyses. For the purpose of
these two analyses, a higher score for SRH indicates a bet-
ter health rating.
LD score regression
LD score regression was performed to obtain genetic
correlations between SRH in UK Biobank and the sum-
mary results of the 16 GWAS consortia and three UK
Biobank traits (Neuroticism, Education and
Intelligence) (Figure 4; Supplementary Table 16, avail-
able as Supplementary data at IJE online). Better SRH
showed positive genetic correlations with intelligence,
education, longevity, anorexia nervosa and forced ex-
piratory volume in 1 s (FEV1) (rg¼ 0.11 to 0.59).
Negative genetic correlations were found between better
SRH and neuroticism, BMI, ADHD, major depressive
disorder, schizophrenia, systolic and diastolic blood
pressure, coronary artery disease, ischaemic stroke and
type 2 diabetes (rg ¼ -0.16 to -0.46).
Table 1. Independent genome-wide significant SNP-based associations for self-rated health
SNP Chr Position A 1 A 2 N P b MAF INFO Genes in
region
Previous gene
associations
rs2360675 2 208059640 A C 111749 1.77x10-10 0.027 0.44 0.99 KLF7 Obesity65 and type 2
diabetes66
rs76380179 6 32460750 T C 111749 6.15x10-10 0.038 0.17 0.82 HLA Class II Auto immune
diseases79
rs7761182 6 32575099 T G 111749 2.13x10-9 0.030 0.22 0.97 HLA Class II Auto immune
diseases79
rs544172318 3 87700891 T C 111749 8.73x10-9 0.23 0.0032 0.85 NA NA
rs4767120 12 114189961 G A 111749 2.79x10-8 0.024 0.40 0.98 AK096932/
BC007399
NA
rs17637472 17 47461433 A G 111749 3.32x10-8 0.024 0.40 0.98 NA NA
rs116828404 15 101390343 A G 111749 3.87x10-8 0.45 0.0012 0.55 LOC145757 NA
rs147141470 3 49638084 A AAAATT 111749 4.01x10-8 0.026 0.29 0.98 BSN Crohn’s disease67
rs35972789 10 75519691 A C 111749 4.30x10-8 0.061 0.038 1 SEC24C NA
rs907662 1 117848822 A G 111749 4.41x10-8 0.027 0.24 0.99 NA NA
rs555785137 16 13015115 G A 111749 4.56x10-8 0.45 0.0012 0.58 SHISA9 NA
rs2924322 18 53244414 T A 111749 4.68x10-8 0.039 0.12 0.84 TCF4 Neurodevelopment-
al disorders and
psychiatric
diseases69
rs10110194 8 119479124 C G 111749 4.98x10-8 0.025 0.35 0.95 SAMD12 Diastolic blood
pressure68
Chr, chromosome; NA, not available.
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Polygenic profile analyses
The results of the polygenic risk score analyses are shown
in Table 2, using the most predictive threshold for each
trait. The numbers of SNPs included in each polygenic
threshold score for each of the 21 health-related traits
are shown in Supplementary Table 17, available as
Supplementary data at IJE online. Higher polygenic profile
scores for years of education, general and childhood cogni-
tive ability, longevity and FEV1 were associated with
higher levels of SRH (standardized b between 0.01 and 0.
06). Higher polygenic profile scores for neuroticism, BMI,
ADHD, major depressive disorder, schizophrenia, diastolic
and systolic blood pressure, coronary artery disease, large
vessel disease stroke and type 2 diabetes were associated
with lower levels of SRH (standardized b between -0.07
and -0.009). The results showed very little change when in-
dividuals with self-reported clinical diagnoses of cardiovas-
cular disease (N ¼ 5300), diabetes (N ¼ 5800) and
hypertension (N ¼ 26 912) were removed from the corres-
ponding analyses (coronary artery disease, type 2 diabetes
and systolic blood pressure). The results including all five
thresholds can be found in Supplementary Table 18, avail-
able as Supplementary data at IJE online.
A multivariate regression model was run including 14
of 15 significant polygenic profile scores (years of
education, childhood cognitive ability, general cognitive
function, neuroticism, BMI, longevity, ADHD, major de-
pressive disorder, schizophrenia, FEV1, systolic blood pres-
sure, coronary artery disease, large vessel disease stroke
and type 2 diabetes) alongside the same covariates as
described previously. Due to the high phenotypic correl-
ation between systolic and diastolic blood pressure, only
systolic blood pressure was included in the model. This
tested the extent to which including all significant poly-
genic profile scores in a multivariate model would improve
the prediction of SRH and discover which polygenic scores
contributed independently. This was done by subtracting
the r2 value of the model only including the covariates
from the model with both covariates and polygenic profile
scores. All polygenic profile scores remained significant,
after FDR correction (P < 0.032), in this multivariate
model, and together accounted for 1.03% of the variance
in SRH (Table 3).
In UK Biobank, BMI was negatively correlated with
SRH (Spearman’s rank correlation ¼ -0.26). A 1-SD in-
crease in BMI polygenic risk score, based on 90 SNPs, was
associated with a 0.12-SD increase in BMI. A 1-SD in-
crease in BMI polygenic risk score was associated with a
0.026-SD decrease in SRH. A genetically determined in-
crease in BMI of 0.58 kg/m2 was associated with a 0.45-
SD decrease in SRH.
Discussion
In the present and other studies, a single item of SRH is
associated with mortality. Such SRH items are widely and
successfully used in health research. Given their predictive
validity, it is of interest to discover the causes of people’s
differences in SRH. Here, in analyses of the large UK
Biobank sample together with results from many GWAS
consortia, we discovered many new genome-wide signifi-
cant genetic variants associated with SRH. A robust esti-
mate of the SNP-based heritability of SRH in the UK was
provided (13%), which is close to that previously reported
(18%) using this method in the US-based Health and
Retirement Survey.21 Extensive pleiotropy was found be-
tween SRH and many physical and psychiatric disorders
and health-related, cognitive and personality traits, indi-
cating that, to a significant degree, the same genetic vari-
ants may influence these traits and SRH. This provides
comprehensive new findings on the overlap between how
individuals rate their health on a four-point scale and the
genetic contributions to intelligence, personality, cardio-
vascular diseases and many psychiatric and physical dis-
orders and traits.
The present study identified novel genes/loci associated
with individual differences in SRH. These include genes
Figure 4. Barplot of genetic correlations calculated using LD score re-
gression between self-rated health in UK Biobank (N ¼ 111 749) and 16
health-related measures from GWAS consortia and three from UK
Biobank (Intelligence, Education and Neuroticism). Self-rated health is
scored such that higher scores indicate a better health rating. *, FDR-
corrected P < 0.0061.
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previously associated with diabetes (KLF7,
MAN1A2),66,77 neurodevelopmental disorders (TC4F,
NRXN1, AUTS2),69,73,74 autoimmune diseases (BSN),67
blood pressure (SAMD12, ZNF652)68,75 and cancer
(ASXL3, AUTS2),76,74 although as yet not at a gold-stand-
ard genome-wide significance level. These results indicate
that genes previously associated with objectively measured
diseases are also associated with SRH, perhaps indicating
that people’s perception of their health does truly reflect
their state of health. The MHC on chromosome 6 was also
shown to be associated with SRH. The MHC is vital for
the correct functioning of the immune system and therefore
genetic variants in this region can have major health impli-
cations, for example HLA-DQA1 which was associated
with SRH in our gene-based analysis, has previously been
associated with coeliac disease.78 HLA allele analysis indi-
cated that the HLA-DQB1*03.02 was most strongly asso-
ciated with SRH. This allele has previously been associated
with several autoimmune diseases including type I diabetes
and multiple sclerosis.79,80 Several genes were identified
using the gene-based analysis in regions that did not con-
tain any genome-wide significant SNPs indicating the im-
portance of gene-based tests. None of our genome-wide
significant SNPs were in regions that approached signifi-
cance in a previous much smaller GWAS of SRH. 19
Sensitivity analyses showed that the polygenic profile
score analyses for systolic blood pressure, coronary artery
disease and type 2 diabetes were not confounded by indi-
viduals with the associated disease (hypertension, cardio-
vascular disease and diabetes mellitus). This indicates that
even in self-rated healthy individuals, a higher polygenic
profile score for systolic blood pressure, coronary artery
disease and type 2 diabetes is associated with lower health
ratings.
The results of the present study indicate that genetic
variants associated with better SRH are associated with a
lower genetic risk of neuroticism, but a higher genetic risk
Table 2. Associations between polygenic profiles of health-
related traits created from GWAS consortia summary data,
and UK Biobank self-rated health controlling for age, sex, as-
sessment centre, genotyping batch and array, and 10 princi-
pal components for population structure (N ¼ 111 749). FDR-
corrected statistically significant values (P < 0.0324) are
shown in bold. Self-rated health is scored such that higher
scores indicate better health ratings. The associations be-
tween the polygenic profile scores with the largest effect size
(thresh) and self-rated health are presented
Trait thresh b P
Years of education 0.5 0.058 6.063 10280
Childhood cognitive ability 0.5 0.025 1.023 10216
General cognitive function 1 0.037 1.293 10230
Neuroticism 0.5 0.017 1.893 1028
BMI 0.5 0.067 8.203 102108
Longevity 0.05 0.011 5.493 1024
ADHD 0.1 0.009 2.133 1023
Alzheimer’s disease 1 0.003 3.50101
Anorexia nervosa 0.01 0.007 3.04102
Bipolar disorder 0.01 0.005 9.59102
Major depressive disorder 1 0.017 3.443 1028
Schizophrenia 1 0.028 2.143 10219
FEV1 1 0.020 7.713 10
212
Blood pressure: diastolic 0.5 0.012 4.773 1025
Blood pressure: systolic 0.1 0.015 9.053 1027a
Coronary artery disease 0.5 0.025 7.193 10217b
Stroke: ischaemic 0.05 0.007 3.24102
Stroke: cardioembolic 0.05 0.006 4.11102
Stroke: large vessel disease 0.05 0.010 1.193 1023
Stroke: small vessel disease 0.1 0.006 5.74102
Type 2 diabetes 1 0.032 1.883 10224c
Thresh, the P-value threshold with the largest effect size.
aExcluding individuals with hypertension b ¼ -0.010, P ¼ 0.005.
bExcluding individuals with cardiovascular disease b ¼ -0.018, P ¼
8.4 10-9.
cExcluding individuals with diabetes b ¼ -0.021, P ¼ 4.0810-11.
Table 3. Multivariate models predicting self-rated health,
including all significant polygenic profile scores together
with covariates (age, sex, assessment centre, genotyping
batch and array, and 10 genetic principal components for
population structure; covariate values not shown here). Self-
rated health is scored such that higher scores indicate better
health ratings. Adjusted R2 values refer to the polygenic pro-
file scores only (excluding variance explained by the covari-
ates). Statistically significant FEV1 ¼ P-values (after FDR
correction; threshold: P < 0.0243) are shown in bold
Self-rated health (N ¼ 111 749)
(adj. R2 ¼ 1.03%)
Trait b P
Years of education 0.046 < 2.003 10216
Childhood cognitive ability 0.017 4.773 1028
General cognitive function 0.019 6.833 1029
Neuroticism 0.014 4.293 1026
BMI 0.058 < 2.003 10216
Longevity 0.007 0.02421
ADHD 0.007 0.01415
Major depressive disorder 0.012 0.00010
Schizophrenia 0.026 2.513 10216
FEV1 0.015 6.643 10
27
Blood pressure: systolic 0.011 0.000385
Coronary artery disease 0.020 1.333 10210
Stroke: large vessel disease 0.007 0.01823
Type 2 diabetes 0.021 2.633 10211
12 International Journal of Epidemiology, 2016, Vol. 0, No. 0
 at Edinburgh U
niversity on D
ecem
ber 5, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
of anorexia nervosa. From a previously published positive
phenotypic association between anorexia nervosa and
neuroticism,81 and our finding that individuals who rate
their health lower had higher levels of neuroticism, one
might have expected that high polygenic risk of anorexia
nervosa would be associated with lower SRH. However,
the polygenic profile score for anorexia nervosa could be
seen on a spectrum, where individuals on the lower end of
the spectrum might be more conscious about their eating
behaviour and health, leading to better SRH, without ex-
ceeding the threshold for a clinical diagnosis of anorexia
nervosa. The summary results of the GWAS for anorexia
nervosa used for both LD score regression and polygenic
profile analyses and were based on 2907 cases and almost
15 000 controls.82 It is possible that this GWAS is picking
some degree of predisposition to healthy behaviour.
Another explanation for this finding is that individuals
with anorexia nervosa potentially have a discrepancy be-
tween their SRH and their actual health, due to the body
image distortion of individuals with anorexia nervosa.
This study was unable to test this hypothesis.
This study shows that the SRH measure, consisting of
only one question, is able to reflect the genetic variants of
traits and disorders, such as intelligence, personality,
cardio-metabolic disease and psychiatric disorders, associ-
ated with actual health. Genetic variants associated with
higher levels of intelligence and lower levels of cardio-
metabolic diseases are associated with better health rat-
ings. This supports the theoretical construct of bodily sys-
tem integrity, a latent trait indicating individual differences
in encountering health and cognitive challenges from the
environment.83 Individuals with better system integrity are
likely to have higher levels of intelligence, fewer diseases, a
better overall health and greater longevity. A test of the hy-
pothesis is whether there are genetic associations between
any cognitive-related trait from youth and later health.
Here, the clearest evidence for this is the large genetic cor-
relation between education—which, for most people, is
completed in youth—and self-rated health in older age.
The strongest association found in this study is between
SRH and the polygenic profile score for BMI, accounting
for 0.45% of the variance. Mendelian randomization indi-
cated that higher genetically determined BMI leads to
lower SRH, although we cannot exclude a causal effect in
the other direction. When combining the polygenic liabil-
ities for multiple traits and disorders in a multivariate
model, the polygenic liabilities together double the amount
of variance to 1%. This implies that SRH may be affected
by risk alleles unique to each trait and disorder.
A strength of this study is the large sample size of UK
Biobank, permitting powerful and robust tests of plei-
otropy between SRH and many health-related traits. Other
strengths include that all individuals were of White British
ancestry, minimizing population stratification. Genotyping
and quality control have been performed in a consistent
way across the whole sample. The use of summary data
from many international GWAS consortia allowed a de-
tailed examination of pleiotropy between SRH and a wide
range of health-related traits, showing many novel esti-
mates of genetic correlations between traits.
The present study has some limitations; several of the
genome-wide significant hits are single SNPs rather than in
a peak. These SNPs should be treated with particular cau-
tion until they are replicated in an independent sample,
which is currently not available. The clumping method
used to derive independent regions for DEPICT analyses
relied on the 1000 Genomes data as a reference panel,
whereas the UK Biobank genotypes were imputed to the
UK10K haplotype and 1000 Genomes reference panels.
Therefore, we may have failed to include regions which
only contained non-1000 Genomes SNPs with P < 1 x 10-5.
The summary data from the GWAS studies curated to per-
form LD score regression and create polygenic profile
scores often originated from consortia studies, which in-
volve meta-analyses across data sets with substantial het-
erogeneity in sample size, genome-wide imputation quality
and measurement of the traits. For the polygenic profile
analyses, we might have overestimated the effects because
of possible overlap of individuals in UK Biobank sample
and some of the cohorts within some of the GWAS consor-
tia. We were unable to quantify the exact overlap, but the
number of overlapping individuals is probably small and
we judge that this will have a minor effect on the results.
Because the analyses were restricted to individuals of white
British ancestry, we are unable to generalize the results be-
yond that group. Therefore, these analyses should be repli-
cated in large samples of individuals with different
backgrounds. For the majority of traits we were unable to
distinguish between type I pleiotropy (a single locus dir-
ectly influencing multiple phenotypes) and type II plei-
otropy (a single locus influencing a cascade of events). The
findings from this study are not necessarily transferable to
other populations, as SRH is influenced by social and cul-
tural components.
Summary
Measuring people’s overall health is difficult, because the
state of the body and mind can be disrupted in many ways,
and people’s perceptions of the same objective bodily state
can differ. Notwithstanding this complexity, the response
to a single subjective question about whether a person is in
good or poor health has proved valid and useful in health
research. The present study has been able to identify many
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genetic contributions to SRH, confirming the complexity
of the contributions to the phenotype and also its partial
foundations in genetic differences. The mechanisms by
which the genes contribute to SRH have still to be deter-
mined. The single subjective item of SRH picks up the con-
tributions from many background systems, including
mental and physical health, as well as cognitive abilities
and personality.
Supplementary Data
Supplementary data are available at IJE online.
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